Catalyst Wire Dossier Catalyst Wire Dossier

IDA with intermediate-dose cytarabine

idarubicin? (not specified)
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IDA with intermediate-dose cytarabine, covering 2020-01-03 to 2020-01-03. Get the full timeline:

Most recent: Clinical Trial Update: Comparing the Consolidation Regimens of IDA With Intermediate-dose Cytarabine Versus Intermediate-dose Cytarabine Alone for Elderly AML Patients [Phase 2, Phase 3]

See pricing